Michigan Cancer Consortium

Michigan Cancer Consortium

Michigan Cancer ConsortiumThe Barbara Ann Karmanos Cancer Institute is a member of the Michigan Cancer Consortium.

The MCC is a statewide, broad-based partnership that strives to include all interested public and private organizations and provides a forum for collaboration to reduce the burden of cancer among the citizens of Michigan by achieving the Consortium's research-based and results-oriented cancer prevention and control priorities. For more information visit the MCC website

Goals of Consortium and its members include:

  • Prevent cancer from occurring
  • Promote early detection of cancer using tests that have been shown to reduce mortality
  • Diagnose and treat all patients using the most effective and appropriate methods
  • Optimize quality of life for every person affected by cancer

The Latest From Karmanos Cancer Institute

News

Study shows social needs linked to low health-related quality of life among African American cancer survivors

Social needs, such as food and economic insecurity, poor housing and neighborhood conditions and lack of access to transportation, were common in ...

Read More

Karmanos Cancer Institute and Wayne State University to host two-day symposium focused on advancing health equity and the impact of COVID-19

Karmanos Cancer Institute and Wayne State University will host the virtual event “Community-Engaged Research Symposium to Advance Health Equity: T...

Read More

Karmanos researchers publish article in ‘Nature Reviews Clinical Oncology’

Karmanos Cancer Institute is pleased to announce that the work of Ramzi Mohammad, Ph.D., member, Molecular Therapeutics Research Program, Karmanos...

Read More